Waiting for the Fruits of Gene Therapy.(Brief Article)

From: Chemical Market Reporter | Date: March 20, 2000| Author: Papanikolaw, Jim | Copyright information

The promise of gene therapy has yet to he realized, but researchers are still hopeful that this next decade will see results.

Gene therapy is one of the many areas in biotechnology that can open new doors for patients, doctors and researchers looking to treat hereditary and non-hereditary diseases. However, whether gene therapy can meet expectations and emerge as a major health care sector remains to be seen.

"During the last 10 years, gene therapy has come cl...

Read all of this article with a FREE trial to HighBeam Research

Related newspaper, magazine, and journal articles from HighBeam Research

GENE THERAPY... UNDER THE MICROSCOPE AGAIN
The Scientist ; Since 1998, when 18-year-old Jesse Gelsinger died in a clinical trial at the University of Pennsylvania, the news on gene therapy hasn't gotten much better. In a recent trial, three children developed leukemia almost certainly brought on by ...
Waiting for the Fruits of Gene Therapy.(Brief Article)
Chemical Market Reporter ; The promise of gene therapy has yet to he realized, but researchers are still hopeful that this next decade will see results. Gene therapy is one of the many areas in biotechnology that can open new doors for patients, doctors and researchers looking to treat hereditary and non-hereditary diseases.
How gene therapy works
China Daily ; In most gene therapy studies, a "normal" gene is inserted into the genome to replace an "abnormal," disease-causing gene. A carrier molecule called a vector must be used to deliver the therapeutic gene to the patient's target cells. Currently, the most common vector is a virus that has been
Primer on Medical Genomics Part X: Gene therapy
Mayo Clinic Proceedings ; Gene therapy is defined as any therapeutic procedure in which genes are intentionally introduced into human somatic cells. Both preclinical and clinical gene therapy research have been progressing rapidly during the past 15 years; gene therapy is now a highly promising new modality for the
Gene therapy cancer cases explained.(Trials)
Chemistry and Industry ; Researchers from 21 research departments in six countries have helped to explain why two children in a high-profile gene therapy trial contracted leukaemia (C&/2003, 3, 4). ft was previously thought that the risk of mutagenesis from gene therapy was low because it had not been seen